Annual Revenue
$314.00 K
+$81.00 K+34.76%
December 31, 2023
Summary
- As of February 7, 2025, ATAI annual revenue is $314.00 thousand, with the most recent change of +$81.00 thousand (+34.76%) on December 31, 2023.
- During the last 3 years, ATAI annual revenue has fallen by -$23.18 million (-98.66%).
- ATAI annual revenue is now -99.52% below its all-time high of $65.59 million, reached on March 1, 2016.
Performance
ATAI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$40.00 K
-$233.00 K-85.35%
September 30, 2024
Summary
- As of February 7, 2025, ATAI quarterly revenue is $40.00 thousand, with the most recent change of -$233.00 thousand (-85.35%) on September 30, 2024.
- Over the past year, ATAI quarterly revenue has dropped by -$47.00 thousand (-54.02%).
- ATAI quarterly revenue is now -99.90% below its all-time high of $39.66 million, reached on December 1, 2016.
Performance
ATAI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$331.00 K
-$47.00 K-12.43%
September 30, 2024
Summary
- As of February 7, 2025, ATAI TTM revenue is $331.00 thousand, with the most recent change of -$47.00 thousand (-12.43%) on September 30, 2024.
- Over the past year, ATAI TTM revenue has dropped by -$3000.00 (-0.90%).
- ATAI TTM revenue is now -99.53% below its all-time high of $71.09 million, reached on December 1, 2016.
Performance
ATAI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ATAI Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +34.8% | -54.0% | -0.9% |
3 y3 years | -98.7% | - | - |
5 y5 years | +55.1% | - | - |
ATAI Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -98.5% | +34.8% | -85.3% | +122.2% | -98.4% | +42.7% |
5 y | 5-year | -98.7% | +34.8% | -99.8% | +122.2% | -99.2% | +42.7% |
alltime | all time | -99.5% | +55.1% | -99.9% | +100.1% | -99.5% | +81.5% |
Atai Life Sciences NV Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $40.00 K(-85.3%) | $331.00 K(-12.4%) |
Jun 2024 | - | $273.00 K(+1416.7%) | $378.00 K(+20.4%) |
Dec 2023 | $314.00 K(+34.8%) | $18.00 K(-79.3%) | $314.00 K(-6.0%) |
Sep 2023 | - | $87.00 K(-49.4%) | $334.00 K(+23.2%) |
Jun 2023 | - | $172.00 K(+364.9%) | $271.00 K(+0.7%) |
Mar 2023 | - | $37.00 K(-2.6%) | $269.00 K(+15.9%) |
Dec 2022 | $233.00 K(-98.9%) | $38.00 K(+58.3%) | $232.00 K(-45.3%) |
Sep 2022 | - | $24.00 K(-85.9%) | $424.00 K(-36.3%) |
Jun 2022 | - | $170.00 K(-26.1%) | $666.00 K(-96.7%) |
Dec 2021 | $20.38 M(-13.3%) | $230.00 K(-13.5%) | $20.38 M(-30.5%) |
Sep 2021 | - | $266.00 K(-98.7%) | $29.32 M(-24.6%) |
Mar 2021 | - | $19.88 M(+116.6%) | $38.88 M(+64.2%) |
Dec 2020 | $23.50 M(+66.0%) | $9.18 M(+50.5%) | $23.68 M(+6.7%) |
Sep 2020 | - | $6.10 M(+63.8%) | $22.19 M(+1.4%) |
Jun 2020 | - | $3.72 M(-20.5%) | $21.89 M(+19.2%) |
Mar 2020 | - | $4.68 M(-39.1%) | $18.36 M(+31.9%) |
Dec 2019 | $14.15 M(+6889.9%) | - | - |
Dec 2019 | - | $7.69 M(+32.7%) | $13.92 M(+122.3%) |
Sep 2019 | - | $5.79 M(+2792.4%) | $6.26 M(+917.7%) |
Jun 2019 | - | $200.30 K(-16.3%) | $615.20 K(+48.3%) |
Mar 2019 | - | $239.40 K(+773.7%) | $414.90 K(+97.8%) |
Dec 2018 | $202.50 K(-73.7%) | $27.40 K(-81.5%) | $209.80 K(+15.0%) |
Sep 2018 | - | $148.10 K(+331.8%) | $182.40 K(-99.3%) |
Mar 2018 | - | $34.30 K(-99.7%) | $25.64 M(+661.0%) |
Dec 2017 | $768.70 K(-41.3%) | - | - |
Sep 2017 | - | $10.43 M(-31.2%) | $3.37 M(+24.5%) |
Jun 2017 | - | $15.17 M(-124.5%) | $2.71 M(+14.7%) |
Mar 2017 | $1.31 M(-98.0%) | -$61.90 M(-256.1%) | $2.36 M(-96.7%) |
Dec 2016 | - | $39.66 M(+306.0%) | $71.09 M(+7.6%) |
Sep 2016 | - | $9.77 M(-34.1%) | $66.07 M(+2.0%) |
Jun 2016 | - | $14.82 M(+116.8%) | $64.78 M(-1.4%) |
Mar 2016 | $65.59 M(+16.1%) | $6.84 M(-80.3%) | $65.67 M(+0.6%) |
Dec 2015 | - | $34.64 M(+308.6%) | $65.30 M(+28.9%) |
Sep 2015 | - | $8.48 M(-46.0%) | $50.66 M(-13.8%) |
Jun 2015 | - | $15.72 M(+143.2%) | $58.80 M(+3.9%) |
Mar 2015 | $56.50 M | $6.46 M(-67.7%) | $56.61 M(-5.3%) |
Dec 2014 | - | $20.00 M(+20.4%) | $59.77 M(-15.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2014 | - | $16.62 M(+22.8%) | $70.77 M(+15.0%) |
Jun 2014 | - | $13.53 M(+40.7%) | $61.51 M(-2.3%) |
Mar 2014 | $62.87 M(+8.0%) | $9.62 M(-69.0%) | $62.94 M(+2.0%) |
Dec 2013 | - | $31.00 M(+321.2%) | $61.71 M(+3.9%) |
Sep 2013 | - | $7.36 M(-50.8%) | $59.39 M(+0.0%) |
Jun 2013 | - | $14.96 M(+78.4%) | $59.38 M(+1.8%) |
Mar 2013 | $58.24 M(+5.9%) | $8.38 M(-70.8%) | $58.35 M(-2.0%) |
Dec 2012 | - | $28.69 M(+290.5%) | $59.53 M(+11.5%) |
Sep 2012 | - | $7.35 M(-47.2%) | $53.40 M(-6.3%) |
Jun 2012 | - | $13.92 M(+45.4%) | $57.01 M(+3.6%) |
Mar 2012 | $54.99 M(+21.7%) | $9.57 M(-57.6%) | $55.02 M(+3.8%) |
Dec 2011 | - | $22.56 M(+105.9%) | $52.99 M(+4.3%) |
Sep 2011 | - | $10.96 M(-8.1%) | $50.81 M(+13.5%) |
Jun 2011 | - | $11.93 M(+58.1%) | $44.76 M(-1.1%) |
Mar 2011 | $45.19 M(+25.9%) | $7.55 M(-63.0%) | $45.27 M(+1.4%) |
Dec 2010 | - | $20.38 M(+315.5%) | $44.63 M(+25.9%) |
Sep 2010 | - | $4.90 M(-60.6%) | $35.46 M(-3.3%) |
Jun 2010 | - | $12.44 M(+80.2%) | $36.65 M(+2.1%) |
Mar 2010 | $35.91 M(+13.2%) | $6.91 M(-38.4%) | $35.91 M(+7.7%) |
Dec 2009 | - | $11.21 M(+83.9%) | $33.35 M(+4.0%) |
Sep 2009 | - | $6.10 M(-47.9%) | $32.08 M(-4.4%) |
Jun 2009 | - | $11.70 M(+169.1%) | $33.55 M(+5.9%) |
Mar 2009 | $31.72 M(+37.2%) | $4.35 M(-56.2%) | $31.69 M(+0.0%) |
Dec 2008 | - | $9.94 M(+31.3%) | $31.68 M(+3.0%) |
Sep 2008 | - | $7.57 M(-23.1%) | $30.74 M(+8.9%) |
Jun 2008 | - | $9.84 M(+126.9%) | $28.23 M(+20.4%) |
Mar 2008 | $23.12 M(+114.8%) | $4.33 M(-51.8%) | $23.44 M(+4.0%) |
Dec 2007 | - | $9.00 M(+78.1%) | $22.54 M(+33.6%) |
Sep 2007 | - | $5.05 M(+0.1%) | $16.88 M(+21.7%) |
Jun 2007 | - | $5.05 M(+46.8%) | $13.86 M(+27.9%) |
Mar 2007 | $10.76 M(+26.6%) | $3.44 M(+3.0%) | $10.84 M(+46.5%) |
Dec 2006 | - | $3.34 M(+63.7%) | $7.40 M(+82.2%) |
Sep 2006 | - | $2.04 M(+0.8%) | $4.06 M(+100.8%) |
Jun 2006 | - | $2.02 M | $2.02 M |
Mar 2006 | $8.50 M(+57.9%) | - | - |
Mar 2004 | $5.38 M(+96.9%) | - | - |
Dec 2003 | $2.73 M | - | - |
FAQ
- What is Atai Life Sciences NV annual revenue?
- What is the all time high annual revenue for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual revenue year-on-year change?
- What is Atai Life Sciences NV quarterly revenue?
- What is the all time high quarterly revenue for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly revenue year-on-year change?
- What is Atai Life Sciences NV TTM revenue?
- What is the all time high TTM revenue for Atai Life Sciences NV?
- What is Atai Life Sciences NV TTM revenue year-on-year change?
What is Atai Life Sciences NV annual revenue?
The current annual revenue of ATAI is $314.00 K
What is the all time high annual revenue for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual revenue is $65.59 M
What is Atai Life Sciences NV annual revenue year-on-year change?
Over the past year, ATAI annual revenue has changed by +$81.00 K (+34.76%)
What is Atai Life Sciences NV quarterly revenue?
The current quarterly revenue of ATAI is $40.00 K
What is the all time high quarterly revenue for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly revenue is $39.66 M
What is Atai Life Sciences NV quarterly revenue year-on-year change?
Over the past year, ATAI quarterly revenue has changed by -$47.00 K (-54.02%)
What is Atai Life Sciences NV TTM revenue?
The current TTM revenue of ATAI is $331.00 K
What is the all time high TTM revenue for Atai Life Sciences NV?
Atai Life Sciences NV all-time high TTM revenue is $71.09 M
What is Atai Life Sciences NV TTM revenue year-on-year change?
Over the past year, ATAI TTM revenue has changed by -$3000.00 (-0.90%)